177 related articles for article (PubMed ID: 38564291)
1. Improved mitochondrial function in the hearts of sarcolipin-deficient dystrophin and utrophin double-knockout mice.
Mareedu S; Fefelova N; Galindo CL; Prakash G; Mukai R; Sadoshima J; Xie LH; Babu GJ
JCI Insight; 2024 Apr; 9(9):. PubMed ID: 38564291
[TBL] [Abstract][Full Text] [Related]
2. Sarcolipin haploinsufficiency prevents dystrophic cardiomyopathy in
Mareedu S; Pachon R; Thilagavathi J; Fefelova N; Balakrishnan R; Niranjan N; Xie LH; Babu GJ
Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H200-H210. PubMed ID: 33216625
[TBL] [Abstract][Full Text] [Related]
3. Reducing sarcolipin expression mitigates Duchenne muscular dystrophy and associated cardiomyopathy in mice.
Voit A; Patel V; Pachon R; Shah V; Bakhutma M; Kohlbrenner E; McArdle JJ; Dell'Italia LJ; Mendell JR; Xie LH; Hajjar RJ; Duan D; Fraidenraich D; Babu GJ
Nat Commun; 2017 Oct; 8(1):1068. PubMed ID: 29051551
[TBL] [Abstract][Full Text] [Related]
4. Truncated dystrophin ameliorates the dystrophic phenotype of mdx mice by reducing sarcolipin-mediated SERCA inhibition.
Tanihata J; Nagata T; Ito N; Saito T; Nakamura A; Minamisawa S; Aoki Y; Ruegg UT; Takeda S
Biochem Biophys Res Commun; 2018 Oct; 505(1):51-59. PubMed ID: 30236982
[TBL] [Abstract][Full Text] [Related]
5. Sarcolipin deletion in mdx mice impairs calcineurin signalling and worsens dystrophic pathology.
Fajardo VA; Chambers PJ; Juracic ES; Rietze BA; Gamu D; Bellissimo C; Kwon F; Quadrilatero J; Russell Tupling A
Hum Mol Genet; 2018 Dec; 27(23):4094-4102. PubMed ID: 30137316
[TBL] [Abstract][Full Text] [Related]
6. Injection of vessel-derived stem cells prevents dilated cardiomyopathy and promotes angiogenesis and endogenous cardiac stem cell proliferation in mdx/utrn-/- but not aged mdx mouse models for duchenne muscular dystrophy.
Chun JL; O'Brien R; Song MH; Wondrasch BF; Berry SE
Stem Cells Transl Med; 2013 Jan; 2(1):68-80. PubMed ID: 23283493
[TBL] [Abstract][Full Text] [Related]
7. Exacerbation of dystrophic cardiomyopathy by phospholamban deficiency mediated chronically increased cardiac Ca
Law ML; Prins KW; Olander ME; Metzger JM
Am J Physiol Heart Circ Physiol; 2018 Dec; 315(6):H1544-H1552. PubMed ID: 30118340
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the cardiac sodium channel Nav1.5 by utrophin in dystrophin-deficient mice.
Albesa M; Ogrodnik J; Rougier JS; Abriel H
Cardiovasc Res; 2011 Feb; 89(2):320-8. PubMed ID: 20952415
[TBL] [Abstract][Full Text] [Related]
9. Sarcolipin overexpression impairs myogenic differentiation in Duchenne muscular dystrophy.
Niranjan N; Mareedu S; Tian Y; Kodippili K; Fefelova N; Voit A; Xie LH; Duan D; Babu GJ
Am J Physiol Cell Physiol; 2019 Oct; 317(4):C813-C824. PubMed ID: 31365291
[TBL] [Abstract][Full Text] [Related]
10. Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle.
Kennedy TL; Moir L; Hemming S; Edwards B; Squire S; Davies K; Guiraud S
Skelet Muscle; 2017 Oct; 7(1):22. PubMed ID: 29065908
[TBL] [Abstract][Full Text] [Related]
11. Nestin expression in end-stage disease in dystrophin-deficient heart: implications for regeneration from endogenous cardiac stem cells.
Berry SE; Andruszkiewicz P; Chun JL; Hong J
Stem Cells Transl Med; 2013 Nov; 2(11):848-61. PubMed ID: 24068741
[TBL] [Abstract][Full Text] [Related]
12. Reducing sarcolipin expression improves muscle metabolism in
Balakrishnan R; Mareedu S; Babu GJ
Am J Physiol Cell Physiol; 2022 Feb; 322(2):C260-C274. PubMed ID: 34986021
[TBL] [Abstract][Full Text] [Related]
13. Cardiomyopathy in the dystrophin/utrophin-deficient mouse model of severe muscular dystrophy is characterized by dysregulation of matrix metalloproteinases.
Delfín DA; Zang KE; Schill KE; Patel NT; Janssen PM; Raman SV; Rafael-Fortney JA
Neuromuscul Disord; 2012 Nov; 22(11):1006-14. PubMed ID: 22749475
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular phenotype of the
Szabó PL; Ebner J; Koenig X; Hamza O; Watzinger S; Trojanek S; Abraham D; Todt H; Kubista H; Schicker K; Remy S; Anegon I; Kiss A; Podesser BK; Hilber K
Dis Model Mech; 2021 Feb; 14(2):. PubMed ID: 33619211
[TBL] [Abstract][Full Text] [Related]
15. Metabolic remodeling of dystrophic skeletal muscle reveals biological roles for dystrophin and utrophin in adaptation and plasticity.
Hardee JP; Martins KJB; Miotto PM; Ryall JG; Gehrig SM; Reljic B; Naim T; Chung JD; Trieu J; Swiderski K; Philp AM; Philp A; Watt MJ; Stroud DA; Koopman R; Steinberg GR; Lynch GS
Mol Metab; 2021 Mar; 45():101157. PubMed ID: 33359740
[TBL] [Abstract][Full Text] [Related]
16. In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice.
El Refaey M; Xu L; Gao Y; Canan BD; Adesanya TMA; Warner SC; Akagi K; Symer DE; Mohler PJ; Ma J; Janssen PML; Han R
Circ Res; 2017 Sep; 121(8):923-929. PubMed ID: 28790199
[TBL] [Abstract][Full Text] [Related]
17. Increased constitutive nitric oxide production by whole body periodic acceleration ameliorates alterations in cardiomyocytes associated with utrophin/dystrophin deficiency.
Lopez JR; Kolster J; Zhang R; Adams J
J Mol Cell Cardiol; 2017 Jul; 108():149-157. PubMed ID: 28623080
[TBL] [Abstract][Full Text] [Related]
18. Lifelong quercetin enrichment and cardioprotection in Mdx/Utrn+/- mice.
Ballmann C; Denney TS; Beyers RJ; Quindry T; Romero M; Amin R; Selsby JT; Quindry JC
Am J Physiol Heart Circ Physiol; 2017 Jan; 312(1):H128-H140. PubMed ID: 27836895
[TBL] [Abstract][Full Text] [Related]
19. Exclusive skeletal muscle correction does not modulate dystrophic heart disease in the aged mdx model of Duchenne cardiomyopathy.
Wasala NB; Bostick B; Yue Y; Duan D
Hum Mol Genet; 2013 Jul; 22(13):2634-41. PubMed ID: 23459935
[TBL] [Abstract][Full Text] [Related]
20. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
